Powered 500 · 2026POWEREDS. 497 of 500
By founding Flagship Pioneering in 2000 and incubating Moderna from scratch, Afeyan helped deliver a COVID-19 vaccine that reached $18 billion in peak annual revenue — proof that proactively inventing companies, not just funding them, works.
Noubar Afeyan founded Flagship Pioneering in 2000, a venture creation firm that invents technologies in-house and builds companies around them.
Flagship has originated more than 100 scientific ventures, including Moderna, which co-developed one of the two leading COVID-19 mRNA vaccines and reached over $18 billion in peak annual revenue. Afeyan also serves as Co-Chairman of Moderna's board.
Interview · In Pipeline
Sponsored placement
An invitation, extended to Powered readers.
Drive the Continental GT S.
Request a test driveBentley T&Cs apply
